Athenix Body Sculpting Institute Achieves Accreditation by AAAHC

December 23, 2020

Athenix Body Sculpting Institute, a leading aesthetic plastic surgery center on the West Coast, was granted a three-year accreditation by Accreditation Association for Ambulatory Health Care (AAAHC) to its Bellevue, Washington and Portland, Oregon facilities.

Athenix Body Sculpting Institute Fresno, CA, location, as well as its Southern California locations, has maintained accreditation by the Institute for Medical Quality (IMQ) at its California locations for the past 10 years.

“We are pleased to announce all five of our Athenix Body Sculpting centers have achieved accreditation by either AAAHC or IMQ,” says  Dr. Gavin Dry, Medical Director of Athenix. “This speaks directly to the extensive safety standards we have put in place for our patients, as well as our ongoing dedication to providing the absolute best patient care and results.”

AAAHC advocates for the provision of high-quality health care through the development and adoption of nationally recognized standards. The AAAHC Certificate of Accreditation demonstrates an organization’s commitment to providing safe, high-quality services to its patients—every day of the 1,095-day accreditation cycle. It is recognized by third party payers, medical professional associations, liability insurance companies, state and federal agencies, and the public.

Over the last decade, Athenix has served over 50,000 satisfied patients throughout the west coast, offering a full spectrum of aesthetic plastic surgery procedures including body contouring, breast augmentation and reduction, as well as the latest minimally-invasive cosmetic procedures. Accreditation further distinguishes Athenix Body Sculpting Institute by recognizing its strict adherence to the rigorous standards of care and safety set forth by the AAAHC.

In order to achieve AAAHC accreditation, Athenix agreed to extensive on-site reviews, ongoing self-evaluation, and a commitment to continuously improve its care and services. The on-site survey was conducted by AAAHC expert surveyors – physicians, nurses, and administrators who are actively involved in ambulatory care. Athenix now joins more than 6,100 ambulatory health care organizations across the United States to be currently accredited by AAAHC.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version